Autolus Therapeutics PLC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
PPF IM Ltd. and related entities have filed an amendment to their Schedule 13D, confirming their beneficial ownership of approximately 5.6% of Autolus Therapeutics plc's shares following an internal reorganization.